Oral nutritional supplements for cirrhotic patients undergoing liver resection assessed by ultrasound measurement of Rectus Femoris and Anterior Tibialis muscles.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR201907570828748

Enrollment

Registered

2019-07-05

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

control

ONS.oral nutritio supplement group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hepatic patients classified as child A, B undergoing liver resection operation), with no past history of nutritional problems chronic use of drugs, orthopedic issues such as skeletal fractures or immobilization

Exclusion criteria

Exclusion criteria: Refusal of the patient to share in the study, relevant comorbidities (renal, heart disease or COPD), previous immune abnormalities including treatment with corticosteroids, neuromuscular diseases, laparoscopic surgery.

Design outcomes

Primary

Measure	Time frame
cross sectional area of rectus femoris and Vastus intermedius muscles over the course of the ICU	—

Secondary

Measure	Time frame
ultrasound measurement of quantitative and qualitative changes of rectus femoris and Vastus intermedius muscles over the course of the ICU . and its impact on liver function, infectious complication and outcome. Inclusion criteria	—

Countries

Egypt

Contacts

Public ContactHESHAM MAGED

heshammaged@yahoo.com002701223548537

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026